IL6 and rheumatoid arthritis: Taken together, these data lend support to the notion that clinically prescribed IL1 and TNF inhibitors for inflammatory conditions (e.g. rheumatoid arthritis) could be used during pregnancy to reduce IL6 trans-signaling and IUI induced adverse consequences.